Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SAN FRANCISCO, AUG. 26, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY ANNOUNCED THAT IT WILL PARTICIPATE IN THE UPCOMING WELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE.

IRHYTHM HOLDINGS TO PARTICIPATE IN WELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE

SHAREHOLDERS ARE ENCOURAGED TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS AND OPTIONS AT NO COST OR OBLIGATION. WE WOULD HANDLE ANY MATTER ON A CONTINGENT FEE BASIS, WHEREBY YOU WOULD NOT BE RESPONSIBLE FOR OUT-OF-POCKET PAYMENT OF OUR LEGAL FEES OR EXPENSES.

DID IRHYTHM TECHNOLOGIES, INC. INSIDERS BREACH THEIR FIDUCIARY DUTIES TO SHAREHOLDERS?

NEW YORK, AUG. 8, 2026 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT IRHYTHM CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE THAT THE ZIO AT MONITOR WAS A REAL-TIME MONITOR INTENDED FOR HIGH-RISK PATIENTS.

KUEHN LAW ENCOURAGES INVESTORS OF IRHYTHM TECHNOLOGIES, INC. TO CONTACT LAW FIRM

SAN FRANCISCO, AUG. 06, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED JUNE30, 2026. SECOND QUARTER 2026 FINANCIAL HIGHLIGHTS REVENUE OF $224.2 MILLION, A 20.1% INCREASE COMPARED TO SECOND QUARTER 2025 GROSS MARGIN OF 72.8%, A 160-BASIS POINT INCREASE COMPARED TO SECOND QUARTER 2025 NET LOSS OF $0.4 MILLION, A $13.8 MILLION IMPROVEMENT COMPARED TO SECOND QUARTER 2025 ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN OF $43.3 MILLION AND 19.3%, RESPECTIVELY, A $27.6 MILLION AND 1,090-BASIS POINT IMPROVEMENT, RESPECTIVELY, COMPARED TO SECOND QUARTER 2025 UNRESTRICTED CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $591.3 MILLION AS OF JUNE30, 2026 INCREASED FISCAL YEAR 2026 REVENUE GUIDANCE TO $880 MILLION TO $890 MILLION AND ADJUSTED EBITDA MARGIN GUIDANCE TO 13.0% TO 14.0% RECENT OPERATIONAL HIGHLIGHTS DELIVERED ANOTHER STRONG QUARTER, DEMONSTRATED BY ROBUST VOLUME LED REVENUE GROWTH AND EXPANDED MARGINS, WITH CONTINUED MOMENTUM ACROSS CARDIOLOGY, PRIMARY CARE, INNOVATIVE CHANNELS, AND INTERNATIONAL MARKETS ENTERED INTO A DEFINITIVE AGREEMENT TO ACQUIRE VITAL CONNECT, INC. ("VITALCONNECT"), A PRIVATELY HELD COMPANY THAT OFFERS COMPLEMENTARY AMBULATORY CARDIAC MONITORING TECHNOLOGY, FOR TOTAL CONSIDERATION OF APPROXIMATELY $287.5 MILLION.

IRHYTHM HOLDINGS ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

NEW YORK, JULY 28, 2026 (GLOBE NEWSWIRE) -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS.

SAN FRANCISCO, JULY 16, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY ANNOUNCED THAT IT WILL RELEASE FINANCIAL RESULTS FOR THE SECOND QUARTER 2026 AFTER THE CLOSE OF TRADING ON THURSDAY, AUGUST 6, 2026. THE COMPANY'S MANAGEMENT TEAM WILL HOST A CORRESPONDING CONFERENCE CALL BEGINNING AT 1:30 P.M. PT / 4:30 P.M. ET.

IRHYTHM HOLDINGS TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 6, 2026

NEW YORK, JULY 2, 2026 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT IRHYTHM CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE THAT THE ZIO AT MONITOR WAS A REAL-TIME MONITOR INTENDED FOR HIGH-RISK PATIENTS.

NEW YORK, JUNE 30, 2026 (GLOBE NEWSWIRE) -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS.

iRhythm Technologies, Inc.

IRTC

Price

Financial Reports

No items found.

Press Releases

iRhythm Technologies, Inc.

IRTC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

IRTC